About Novartis Pharmaceuticals Corporation
About novartis Pharmaceutical Corporation

Leadership

The success of Novartis Pharmaceuticals Corporation (NPC) is made possible by the members of our Pharma Executive Committee (PEC). Our Novartis Pharmaceuticals Corporation Pharma Executive Committee (PEC) consists of respected industry leaders and visionaries who share a common passion for innovation and excellence in execution.

Andy Wyss

André Wyss

President, Novartis Pharmaceuticals Corporation

Read bio
 

Usman Azam, M.D.

Vice President & Head of US Medical & Drug Regulatory Affairs

Read bio
 
Steven Baert

Steven Baert

Vice President & Head of Human Resources

Read bio
 
Cynthia Cetani

Cynthia Cetani

Vice President & Chief Compliance Officer

Read bio
 
Nikos Georgiades

Nikos Georgiades

Vice President & Head of Primary Care & Established Medicines Business Unit

Read bio
 
Brian Hanifin

Brian Hanifin

Vice President, Head of Pharmaceutical Operations U.S.

Read bio
 
Siddharth Kaul

Siddharth Kaul

Vice President & Chief Financial Officer

Read bio
 
Jesus Leal

Jesus Leal

President & Head of Respiratory Business Unit

Read bio
 
Carol Lynch

Carol Lynch

Vice President & Head of Specialty Business Unit

Read bio
 
Patrice Matchaba

Patrice Matchaba

Head, Global Development, U.S

Read bio
 
Gregory Oakes

Gregory Oakes

Vice President & Head of US Managed Markets & Market Access

Read bio
 
Rhonda Crichlow

Rhonda Crichlow

Vice President, Head of Diversity & Inclusion

Read bio
 
Kevin Rigby

Kevin T. Rigby

Vice President & Head of Public Affairs & Communications

Read bio
 
Dagmar Rosa-Bjorkeson

Dagmar Rosa-Bjorkeson

Vice President & Head of Multiple Sclerosis Business Unit

Read bio
 
Dagmar Rosa-Bjorkeson

Christi Shaw

Head Novartis Oncology, North American Region

Read bio
 

Thomas Kendris

Vice President & General Counsel

Read bio
 
 

BUSINESS CONDUCT

Business integrity and values are key drivers of success for Novartis Pharmaceuticals Corporation.

OTHER NOVARTIS COMPANIES

Looking for more information?